Novavax Inc. (NVAX) Fundamentals

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
SHARE INFORMATION
Market Cap$ 1,296,885,287
Shares Outstanding78,503,952
Float78,245,664
Percent Float99.67%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,146,290,000
Latest Fiscal EPS$ -23.42
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions878
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months5,648,581
Institutional Holdings Percent79.1%
Institutional Sold Previous 3 Months12,233,191
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months43,219
Insider Holdings Percent2.2
Insider Sold Previous 3 Months20,195
Insider Shares Owned1,754,237
TRADING INFO
52 Week High$ 236.50
52 Week Low$ 15.53
52 Week High Change$ -89.80
21 Day Moving Average$ 19.3071
21 Day Extended Moving Average$ 18.7368
50 Day Moving Average$ 19.6086
50 Day Extended Moving Average$ 22.0377
200 Day Moving Average$ 45.9326
200 Day Extended Moving Average$ 52.4954
10 Day Average Volume4,651,405
20 Day Average Volume4,686,010
30 Day Average Volume4,752,412
50 Day Average Volume5,222,684
Alpha0.050381
Beta1.7580
Standard Deviation0.426383
R20.048135
7 Day Price Change$ -0.02
7 Day Percent Change-0.12%
21 Day Price Change$ -8.52
21 Day Percent Change-34.03%
30 Day Price Change$ -3.98
30 Day Percent Change-19.41%
Month to Date Price Change$ 0.03
Month to Date Percent Change0.18%
Quarter to Date Price Change$ -1.68
Quarter to Date Percent Change-9.23%
180 Day Price Change$ -39.45
180 Day Percent Change-70.48%
200 Day Price Change$ -31.48
200 Day Percent Change-65.58%
Year to Date Price Change$ -126.55
Year to Date Percent Change-88.45%

Novavax Inc. (NVAX) Key Ratios

PROFITABILITY
EBIT Margin-53.5%
EBITDA Margin-52.5%
Pre-Tax Profit Margin-460.1%
Profit Margin Count-86.22%
Gross Margin69.8%
Profit Margin TOT-86.22%
INCOME STATEMENTS
Revenue$ 1,533,325,000
Revenue Per Share$ 19.5318
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.90
Total Debt To Equity6.70
Int Coverage-62.60
Current Ratio1.10
Leverage Ratio-8.10
Quick Ratio0.80
Long Term Debt To Capital0.41
VALUATION MEASURES
PE Ratio-0.90
Enterprise Value$ 454,398,287
Price to Sales0.845799
Price to Free Cash-1.80
PE High Last 5 Years-1.70
Price To Book49.50
Price To Cash Flow11.10
PE Low Last 5 Years-15.60
Price to Tangible Book-1.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.70
Invoice Turnover17.50
Assets Turnover0.30
Return Assets-54.70
Return on Equity2,526.49
Return on Capital-334.22

Novavax Inc. (NVAX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOStanley Charles Erck
Emplyoees1541
Last AuditUQ
CIK0001000694
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address21 Firstfield Road
Gaithersburg, MD 20878
Websitehttps://www.novavax.com
Facsimile-
Telephone+1 240 268-2000
Emailir@novavax.com


Your Recent History
NASDAQ
NVAX
Novavax
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.